2 results
Approved WMOPending
To evaluate the efficacy of Arnica om postoperative outcome after upper blepharoplasty.
Approved WMOCompleted
To assess the effect of switching CML patients, who have been treated with imatinib *2 years and who have stable detectable molecular residual disease above 0.01% (IS), to the combination of Nilotinib and PegIFN, in terms of the proportion of…